Regency Capital Management Inc.\DE
Position in AURA — Aura Biosciences, Inc.
CIK 1863894
HONOLULU, HI
Position in AURA
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$3,562,391
+$627,109 QoQ
Shares Held
532,495
-1.1% QoQ
Ownership
0.515%
of shares outstanding
% of Portfolio
1.95%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2022
16 quarters on record
Voting authority
Sole 3%
Shared 0%
None 97%
Common Shares in AURA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Regency Capital Management Inc.\DE holds $3,940,821 across 3 Biotechnology names. AURA ranks #1 (90.4% of the industry book) .
All Filings in AURA
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,562,391 | 532,495 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $2,935,282 | 538,584 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $3,786,418 | 612,689 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $4,168,415 | 665,881 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $4,391,964 | 749,482 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $5,009,465 | 609,424 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $5,945,741 | 667,311 | Shares | Sole | 2024-10-04 | |
| 2024-06-30 | $5,783,815 | 765,055 | Shares | Sole | 2024-08-21 | |
| 2024-03-31 | $6,163,317 | 785,136 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $6,246,069 | 704,974 | Shares | Sole | 2024-01-23 | |
| 2023-09-30 | $4,726,992 | 526,978 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $6,574,312 | 532,333 | Shares | Sole | 2023-08-01 | |
| 2023-03-31 | $5,045,304 | 543,675 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $5,820,003 | 554,286 | Shares | Sole | 2023-01-27 | |
| 2022-09-30 | $4,068,918 | 224,554 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $3,607,993 | 254,622 | Shares | Sole | 2022-08-03 | |
| No filing history on record for this holder in this stock. | ||||||